T he primary aim of this paper is to describe some of the psychosocial and lifestyle implications of lipodystrophy as experienced by HIV positive individuals being treated with highly active antiretroviral therapy (HAART). Undoubtedly, HAART for HIV and prophylactic therapy for opportunistic infections have increased survival and wellbeing. 1 Yet, in recent years lipodystrophy has been reported in HIV infected patients taking standard therapy protease inhibitors in combination with nucleoside analogues, with a concomitant link being suggested between nucleoside reverse transcriptase inhibitors and factors related to duration of HIV-1 infection itself.
2-5 Carr and colleagues 6 described the syndrome of peripheral lipodystrophy (fat wasting of the face, limbs, and upper trunk), hyperlypidaemia, and insulin resistance in patients receiving potent HIV protease inhibitive therapy, noting that the prevalence and severity of lipodystrophy syndrome with long term therapy for HIV-1 infection including a protease inhibitor is unknown. 7 Whereas most lipodystrophy research has focused on aetiology, diagnosis, and treatment, there is a growing interest and concern over its psychosocial and lifestyle implications. The small number of published studies show that lipodystrophy can have an adverse effect on the sexual behaviour and general wellbeing of HIV infected individuals. [8] [9] [10] [11] At the recent XIV International AIDS Conference a number of presentations on lipodystrophy highlighted issues such as impact on quality of life, 12 body image and sexual behaviour, 13 and adherence to antiretroviral therapy. 14 We wish to augment this knowledge base by presenting qualitative data from in-depth interviews conducted with HIV positive clinic patients on HAART who were experiencing lipodystrophy. For some years now these issues have been raised in the popular media, especially the gay press, as well as on the internet.
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METHODS
Participation and recruitment
Fourteen in-depth interviews were conducted with HIV infected patients who were experiencing lipodystrophy and who were attending a large central London STI/HIV outpatient clinic. All respondents were referred by clinicians who had made a visual assessment of lipodystrophy. Commonly reported among the patients was facial atrophy (12/14) ; wasting of the arms (10/14), legs (10/14), or buttocks (10/14) ; fat deposition at the neck (2/14), abdomen (5/14) , and breast (the two female respondents). The study was explained to them and an information sheet was provided. This outlined its purpose and gave details of ethical approval that had been granted by the relevant health trust. Written consent was obtained from all patients before interview. None of the patients who were referred to the research team refused to be interviewed. Interviews lasted between 45 minutes and 3 hours and took place in a variety of contexts, including the homes of the patients and offices at the clinic. Interviews were tape recorded and transcribed verbatim. They were then analysed using the tenets of grounded theory. 18 In practice, this entailed a thematic analysis of the transcripts from which "categories" and "subcategories" were created. A process of constant comparison between interviews was used to consolidate dominant themes and data collection ceased when "saturation" was achieved, with themes and scenarios being repeated in successive interviews. All transcripts were analysed by at least two of the authors to ensure reliability. This allowed for discussions to be held to agree upon consensual categories and subcategories.
RESULTS
The following sections summarise the main "categories" (numbered) and "subcategories" (lettered) derived from the data with illustrations being drawn from the transcribed See end of article for authors' affiliations interview transcripts. Table 1 describes pertinent characteristics of the sample.
(1) The effect on the individual (A) Awareness and physical effects Initial awareness of lipodystrophy chiefly occurred through individuals noticing physical changes to their body shape or through comments from friends and acquaintances. Awareness also resulted from patients realising that clothes no longer fitted, or looking at old photographs of themselves and identifying differences.
The main effect for me has been an enormous abdomen, and certainly initially I lost weight in general but gained a great deal abdominal size. And I suppose this was put down to, in my mind at least, lipodystrophy. On the whole I'm left a bit freakish. I really should have braces for my underpants now as well for my trousers. (Interviewee (I) 2, male, 46 years old) I'm so vain. I used to have a lovely bum. Now it's flat. And that's a strange one, sitting on a seat and it hurts. Because you've lost all the padding on your backside . . . You still find yourself occasionally walking past a mirror and looking in and it catches you big time. The other big one is photographs. At Christmas photos were taken and you look at a photograph of you and it's not you. (I 3, male, 36 years old)
Body shape changes were accompanied by physical effects, ranging from uneven weight gain and weight loss, reduced libido, and a perception of rapid ageing, especially in the face. More directly, fat loss to the buttocks made sitting uncomfortable.
Losing fat from your legs makes your varicose veins show much more, so it seemed really to be a blessing to society on the whole if I wasn't seen in public undressed. (I 2, male, 46 years old) These physical effects often led to a heightened awareness and a search for knowledge about the condition, most frequently through the gay press and internet websites dedicated to this topic.
I'd seen it advertised in AIDS manuals and they had a name for it, there was a reason why I was losing weight in the face and arms. There was a name for a disease for what was actually happening. (I 9, male, 39 years old) The changes in body shape had economic implications. Clothes no longer fitted and had to be replaced. This was a particular issue for women, where it was common for lipodystrophy to result in the top half of the body requiring a larger dress size than the bottom half.
I just put on weight. I was normally a size fourteen and then I put on weight to a size eighteen and then from there I thought I was putting on weight and I was doing exercise and then I stopped. My stomach was too big on the top part and the bottom side too small. You know you are just in front of the mirror and you say no this is not me. It's someone else. Lipodystrophy was seen as a new signifier of HIV status, especially among the homosexual community, which was deemed to be best informed about the condition. In this sense, it was perceived as the "Kaposi's sarcoma of the 21st century,"as one respondent described it. Although respondents believed there to be low levels of awareness among the general public, it was considered to be only a matter of time before knowledge levels increased. This was particularly problematic for those concerned about HIV status disclosure. For those more open and confident about disclosing their HIV status, this was less of a concern. You spot it yourself, your boyfriend, your friends, strangers. Because it follows certain lines. And so therefore I think I'm more aware of it. But general Joe Public? I doubt it, no. They realise that you look ill. People come up to you and say, "have you been ill?" (I 3, male, 36 years old) Although friends noticed and commented on the condition, those knowledgeable about HIV disease and its consequences were likely to be accepting and understanding, whereas those with limited knowledge were less so.
What with losing so much weight. I am having a lot of panics. If I'm with people who don't know, and not everyone knows I'm HIV positive, you just start making up little white lies, just trying to cover up, but it goes on so long people start to say "What's happened, you look awful?" (I 10, male, 28 years old)
I was a bit depressed I thought "oh it does show, people do notice." (I 4, male, 59 years old)
As noted above, a supportive partner was likely to have a protective effect on the individual.
He (partner) always says it's okay, you look alright. We've been together two and a half years. It's nice of him to say that I look alright, but to me I don't look alright. (I 10, male, 28 years old)
Reactions from strangers were liable to have a negative effect, such as casual remarks about change in weight and body shape. The women interviewed were especially sensitive in this area, particularly when casual comments were made about their body shape changes, which some mistook as early indicators of pregnancy. Friends ask: "oh, are you pregnant?" (I 11, female, 30 years old)
One man felt he had been overlooked for promotion at work because of his appearance and plummeting self confidence.
Responses from family members were varied and depended to some extent upon their previous attitudes towards HIV infection. Some noticed body shape changes and discussed these with the interviewee, others said nothing. For those who had been very ill before going on HAART or who had been through several treatment regimens, lipodystrophy was more likely to be accepted and seen as an unfortunate by-product of HIV disease and concomitant treatment.
I've been living with this thing for fifteen years, so well I am just grateful every day that I am still alive and I know without these pills I certainly probably would be dead, so it's striking the balance. (I 8, male, 41 years old) These individuals seemed less likely to want to change treatment and/or take breaks from their current treatment regimens, though all had thought about this as an option.
I have thought of taking one of these drug holidays . . . but I know what it was like before I started taking these tablets. I was constantly sick . . . It was very depressing . . . The question is should you stop and risk getting sick again? (I 10, male, 59 years old) I'd rather be alive and out there, rather than being lying half dead in hospital because I was so vain I stopped taking the drugs. (I 3, male, 36 years old) For some the decision around medication and HAART was complicated by external issues, such as parental responsibilities.
I have to stay well for my kids, not taking medication is not an option. (I 11, female, 30 years old)
Indeed, some could see positive outcomes of lipodystrophy, such as increased levels of energy from improved diet and additional regular exercise. One even spoke of the positive benefits of early retirement that came as a result of his condition.
I just watch what I eat, but then again on the other side, it's made me eat, eat fatty stuff. It's pushed me towards joining a gym, which I need to do anyway, and I'm taking steroids which helps things along. (I 9, male, 39 years old) (B) Practical response Some had made no major changes in their lives as a result of lipodystrophy. Others had taken positive steps to ameliorate the condition, including eating more, joining a gym, taking steroids, and seeking plastic surgery (especially collagen injections in the cheeks of the face).
He (plastic surgeon) is going to fill the dips in the cheeks, which will help to reduce the lines, because my cheeks have gone down so much it's suddenly become very, very prominent. So that's what we're going to do. (I 3, male, 36 years old) Others, convinced of the link between lipodystrophy and HAART, reported having taken breaks from drug therapy or trying new combinations of drugs. Less direct measures entailed joining a support group or buying new clothes to disguise the changes in body shape. A common response was to seek referral for additional psychological or dietary help.
My doctor referred me to see the psychologist and the dietitian. One for the head, one for the body. It's helped. (I 14, male, 39 years old)
(C) Relationship with doctor
Respondents reported an initial reluctance to speak with their doctor regarding actual or potential concerns about lipodystrophy, as it was perceived as trivial and wasting the doctor's time. However, there was a general feeling that patients' concerns were listened to and that the doctors took them seriously, though it was sometimes felt there was not enough time in a routine consultation to address these issues and concerns. I know someone whose doctor was virtually dismissive, you know this isn't an issue that we need to deal with, you've been through a lot of illness, you're lucky to be here really, you're on this combination therapy-you can't expect everything to be all right, you're just going to have to put up with it. But now, now there's a lot of people presenting with it and a lot of people are experiencing a lot of problems psychologically, and physically people are looking quite different. I think this is being taken seriously and that is validated for me that I am allowed to be worried about it and I don't feel it's me being neurotic. It's something important. (I 6, male, 59 years old) All 14 respondents answered affirmatively to a general question about the need for more psychosocial support for those concerned about lipodystrophy.
The future
Worry and concern about the future was common, especially relating to uncertainty and fear about the longer term prognosis and development of lipodystrophy. On the other hand, those who had many years' experience of the complications of HIV disease, and especially those who had been close to death, were not unduly concerned about the future. Ultimately, and with all the caveats outlined above, a counterbalancing view was that the complications resulting from lipodystrophy were an acceptable, albeit undesirable, price to pay for longevity.
The side effects, I suppose are quite small, when you consider that I could be dead. (I 1, male, 48 years old) In the middle of a tragedy you have to be able to laugh . . . Fat loss aside, terrible feelings aside, the greater thing is I want to stay alive and people will have to take me as I am. (I 13, male, 61 years old)
DISCUSSION
The psychosocial and lifestyle impacts of lipodystrophy reflect concerns raised more generally in studies of body shape change and body image. These range from preoccupation with the body (body cathexis) and behavioural elements (avoidance of situations where the body's perceived inadequacies are highlighted), to comfort, competence, predictability (or lack of it), as well as appearance. 19 Lipodystrophy can negatively impact on body shape and functioning, raising issues of illness and mortality, and can have a detrimental effect on relationships with others, not least because of fears about unwanted disclosure of HIV status. 20 21 Although it may be perceived as an unfortunate complication of HIV disease, our data confirm the recent studies referred to in the introduction which show lipodystrophy can cause physical and psychological discomfort, leading to reduced self esteem and self confidence, resulting in poor social functioning and social isolation. This stated, it should be noted that our sample was derived from those attending a large metropolitan HIV/STI clinic and we need to conduct similar qualitative, as well as complementary quantitative, studies among other groups from other settings. None the less, our data indicate the need for healthcare professionals to address these issues, be they related to diet, body image, HIV status disclosure, drug therapy adherence, or other issues. We need to work towards as clear a case definition as is possible in order to refer relevant patients to specialist help. 22 A number of lipodystrophy clinics have already been established at existing HIV services, providing a range of services including psychological support, and advice on lifestyle issues such as diet and exercise. In this context we need to consider the place of patient involvement in antiretroviral treatment decisions. 23 Although our sample was clinic based, there is a suggestion from the data of the need to assess and respond to the differing experiences and needs of varying groups. For example, it is likely that responses to the needs of homosexual men and heterosexual women will diverge along certain lines and that the cultural imperatives of ethnic minorities around issues such as HIV status disclosure might need particular attention in light of lipodystrophy. To this end we need to conduct formative evaluations to assess and explore the potential for targeted interventions, including education and awareness raising programmes.
